Document Detail

Development of new cyclic plasmin inhibitors with excellent potency and selectivity.
MedLine Citation:
PMID:  23294255     Owner:  NLM     Status:  Publisher    
The trypsin-like serine protease plasmin is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss. The optimization of our recently described substrate-analogue plasmin inhibitors, which were cyclized between their P3 and P2 side chains, provided a new series with improved efficacy and excellent selectivity. The most potent inhibitor 8 binds to plasmin with an inhibition constant of 0.2 nM, whereas Ki values > 1 µM were determined for nearly all other tested trypsin-like serine proteases, with the exception of trypsin, which is also inhibited in the nanomolar range. Docking studies revealed a potential binding mode in the widely open active site of plasmin that explains the strong potency and selectivity profile of these inhibitors. The dialkylated piperazine-linker segment contributes to an excellent solubility of all analogues. Based on their overall profile the presented inhibitors are well suited for further development as injectable antifibrinolytic drugs.
Sebastian M Saupe; Stephanie Leubner; Michael Betz; Gerhard Klebe; Torsten Steinmetzer
Related Documents :
23841875 - Deconstructing activation events in rhodopsin.
8589645 - Modulation of the neuraminidase activity of hn protein from newcastle disease virus by ...
24047895 - Novel insights into eukaryotic γ-glutamyltranspeptidase 1 from the crystal structure o...
24525285 - Neurotoxicity induced by antineoplastic proteasome inhibitors.
21982365 - Protease regulation: the yin and yang of neural development and disease.
18294135 - An essential tryptophan residue in alkaline phosphatase from pearl oyster (pinctada fuc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-8
Journal Detail:
Title:  Journal of medicinal chemistry     Volume:  -     ISSN:  1520-4804     ISO Abbreviation:  J. Med. Chem.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9716531     Medline TA:  J Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Analysing 2 × 2 contingency tables: which test is best?
Next Document:  Transbronchial cryo-biopsy in lung transplantation patients: First Report.